Lilian Nkirote Njagi

Lilian Nkirote Njagi

Auto-generated profile, based on publicly available information

Lilian Nkirote Njagi

Centre for Respiratory Diseases Research, Kenya Medical Research Institute , Nairobi

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
VNVidelis Nduba
Videlis Nduba
LNLilian N. Njagi
Lilian N. Njagi
WMWilfred Murithi
Wilfred Murithi
ZMZipporah Mwongera
Zipporah Mwongera
JBJodi Byers
Jodi Byers
DHDavid J. Horne
David J. Horne
Interrupting transmission events is critical to tuberculosis control. Cough-generated aerosol cultures predict tuberculosis transmission better than microbiological or clinical markers. We hypothesize that highly infectious individuals with pulmonary tuberculosis (positive for cough aerosol cultures) have elevated inflammatory markers and unique transcriptional profiles compared to less infectious individuals. We performed a prospective, longitudinal study using cough aerosol sampling system. We enrolled 142 participants with treatment-naïve pulmonary tuberculosis in Kenya and assessed the association of clinical, microbiologic, and immunologic characteristics with Mycobacterium tuberculosis aerosolization and transmission in 129 household members. Contacts of the forty-three aerosol culture-positive participants (30%) are more likely to have a positive interferon-gamma release assay (85% vs 53%, P = 0.006) and higher median IFNγ level (P < 0.001, 4.28 IU/ml (1.77-5.91) vs. 0.71 (0.01-3.56)) compared to aerosol culture-negative individuals. We find that higher bacillary burden, younger age, larger mean upper arm circumference, and host inflammatory profiles, including elevated serum C-reactive protein and lower plasma TNF levels, associate with positive cough aerosol cultures. Notably, we find pre-treatment whole blood transcriptional profiles associate with aerosol culture status, independent of bacillary load. These findings suggest that tuberculosis infectiousness is associated with epidemiologic characteristics and inflammatory signatures and that these features may identify highly infectious persons.

17 May 2023 in BMJ Open Respiratory Research
Verified
Journal Article
Open access
PDF file
LNLilian Nkirote Njagi
Lilian Nkirote Njagi
VNVidelis Nduba
Videlis Nduba
MMMarianne Wanjiru Mureithi
Marianne Wanjiru Mureithi
JMJared Ongechi Mecha
Jared Ongechi Mecha
Background: Tuberculosis (TB) disease is the leading cause of mortality among people living with HIV (PLHIV). Interferon-gamma release assays (IGRAs) are approved for TB infection ascertainment. However, current IGRA data on the prevalence of TB infection in the context of near-universal access to antiretroviral therapy (ART) and TB preventive therapy (TPT) are lacking. We estimated the prevalence and determinants of TB infection among PLHIV within a high TB and HIV burden context. Methods: This cross-sectional study included data from adult PLHIV age ≥18 years in whom QuantiFERON-TB Gold Plus (QFT-Plus) assay, an IGRA, was performed. TB infection was defined as a positive or indeterminate QFT-Plus test. Participants with TB and those who had previously used TPT were excluded. Regression analysis was performed to identify independent predictors of TB infection. Results: Of 121 PLHIV with QFT-Plus test results, females were 74.4% (90/121), and the mean age was 38.4 (SD 10.8) years. Overall, 47.9% (58/121) were classified as TB infection (QFT-Plus test positive and indeterminate results were 39.7% (48/121) and 8.3% (10/121), respectively). Being obese/overweight (body mass index ≥25 kg/m2; p=0.013, adjusted OR (aOR) 2.90, 95% CI 1.25 to 6.74) and ART usage for >3 years (p=0.013, aOR 3.99, 95% CI 1.55 to 10.28) were independently associated with TB infection. Conclusion: There was a high TB infection prevalence among PLHIV. A longer period of ART and obesity were independently associated with TB infection. The relationship between obesity/overweight and TB infection may be related to ART use and immune reconstitution and requires further investigation. Given the known benefit of test-directed TPT among PLHIV never exposed to TPT, its clinical and cost implications for low and middle-income countries should be explored further.

21 February 2026 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Open access
JZJerry Simbarashe Zifodya
Jerry Simbarashe Zifodya
LKLucy A Kijaro
Lucy A Kijaro
VNVidelis Nduba
Videlis Nduba
MKMst Shamima Khatun
Mst Shamima Khatun
LNLilian N Njagi
Lilian N Njagi
DHDavid J Horne
David J Horne
Rationale: Post-tuberculosis lung disease (PTLD), which includes restrictive and obstructive patterns of impairment, develops in 50% or more of survivors of tuberculosis (TB), yet mechanisms and associated risk factors are poorly understood. Objectives: We sought to identify clinical and transcriptomic risk factors for PTLD phenotypes. Methods: In a prospective, observational, cohort study, we enrolled adults (month 0) with newly diagnosed pulmonary TB in Nairobi, Kenya, and evaluated clinical and transcriptomic risk factors for PTLD. Participants completed 6 months of standard anti-TB therapy. PTLD was defined as abnormal spirometry at month 12 (ie, 6 months posttreatment) with either a restrictive or obstructive pattern. Measurements and Main Results: We enrolled 205 participants, of whom 103 (50.2%) had PTLD, including 60 with restrictive PTLD and 43 obstructive PTLD. Participants with PTLD had lower mid-upper arm circumference (MUAC) and cough peak flow. In multivariable analyses, having more lung quadrants involved on radiograph at diagnosis was a risk factor for both restrictive PTLD (adjusted odds ratio [aOR], 2.1; P <.001) and obstructive PTLD (aOR, 2.2; P <.001). Prior TB was associated with obstructive PTLD (aOR, 5.4; P <.001). Gene expression improved clinical predictive models. In transcriptomic analyses, restrictive PTLD was associated with upregulation of IL-6/JAK/STAT3 and TNF-α signaling at diagnosis (false discovery rate [FDR] <0.2). In contrast, obstructive PTLD was associated with transcriptomic upregulation of IFN-α and IFN-γ signaling responses (FDR <0.2) at month 6. Conclusions: Despite common clinical risk factors (lower MUAC, radiographic lung involvement), PTLD phenotypes have unique transcriptional signatures. Restrictive PTLD is marked by early profibrotic inflammation. In contrast, obstructive PTLD is characterized by persistent inflammation at treatment completion.

10 February 2025 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
LNLilian N Njagi
Lilian N Njagi
KTKhai Hoan Tram
Khai Hoan Tram
JZJerry Simbarashe Zifodya
Jerry Simbarashe Zifodya
SPSharmila Paul
Sharmila Paul
JRJennifer M Ross
Jennifer M Ross
DHDavid J Horne
David J Horne
Background: The role of active case-finding (ACF) in improving tuberculosis (TB) prevention and care depends on the infectiousness of persons with undiagnosed TB and the accuracy of screening strategies. To compare undiagnosed community dwellers to persons presenting for healthcare, we evaluated clinicodemographic and microbiologic characteristics, cough aerosol culture (CAC) status, and household contact (HHC) QuantiFERON-Plus (QFT) status by case-finding approach in adults with pulmonary TB. Methods: We enrolled 388 Kenyan adults with GeneXpert (excluding trace) and/or culture-confirmed, untreated TB through healthcare presentation (passive case-finding [PCF]; 87%) or ACF (community-based prevalence survey). Interventions included cough aerosol sampling and HHC QFT testing. We performed mixed-effect logistic regression to predict transmission, clustered on index participants. Results: World Health Organization–recommended screening symptoms (W4SS) were more common in the PCF cohort (99% vs 73%, P < .001). Traditional makers of infectiousness were less frequent in the ACF cohort. Higher symptom burden (number of reported World Health Organization-recommended 4-symptom screen) associated with higher bacillary burden (lower GeneXpert Ct) (estimate −0.55; 95% confidence interval [CI], −.98 to −.13; P = .01). Among 263 participants with CAC, 21% were CAC-positive, none of whom enrolled through ACF. Among 270 HHCs, QFT positivity differed by index CAC status (89% vs 56% in HHCs of CAC-positive and negative participants, respectively; P < .001) but not by traditional infectiousness makers or case-finding approach. Index CAC-positive status (adjusted odds ratio [aOR], 11.2; CI, 2.2–58.3), HIV-positive status (aOR, 0.1; CI, .0–.6), and HHCs age (aOR, 1.04; CI, 1.01–1.08), independently predicted HHC QFT positivity. Conclusions: Our findings suggest that ACF may detect a smaller proportion of CAC-positive persons with TB than PCF.

5 May 2024 in Tuberculosis
Verified
Journal Article
Open access
LNLilian N. Njagi
Lilian N. Njagi
GKGrace Kaguthi
Grace Kaguthi
JMJared O. Mecha
Jared O. Mecha
THThomas R. Hawn
Thomas R. Hawn
VNVidelis Nduba
Videlis Nduba
Introduction: Exposure to Non-tuberculous Mycobacteria (NTM) varies regionally and may partly explain the disparate outcomes of BCG vaccination and tuberculosis (TB) susceptibility. Methods: We examined NTM sputum colonization, associations with clinical characteristics, and tuberculin skin test (TST) responses in an adolescent TB prevalence survey. Results: Among 5004 adolescents screened, 2281 (45.5 %) were evaluated further. TB and NTM prevalence rates were 0.3 % and 8.0 %, respectively. Among 418 NTM isolates, 103 were unidentifiable, and 315 (75 %) comprised 15 species, the most frequent being M. intracellulare (MAC) (108, 26 %), M. scrofulaceum (96, 23 %) and M. fortuitum (51, 12 %). "NTM colonized" adolescents had less frequent chronic cough and night sweats (adjusted odds ratio [aOR] 0.62, 95 % confidence interval [CI] 0.44-0.87and aOR 0.61, CI 0.42-0.89 respectively), and lower TST induration (median 11 mm (interquartile range [IQR] 0-16) vs 13 mm (IQR 6-17; p = 0.006)) when compared to "NTM not colonized" participants. MAC, but not M. scrofulaceum or M. fortuitum, was associated with decreased TST induration (median 7.5 mm (IQR 0-15) vs 13 mm (IQR 6-17) among "MAC colonized" vs "not colonized", p = 0.001). Conclusion: We observed high NTM prevalence rates with species-specific associations with TST induration, consistent with a model of species-dependent heterologous immunity among mycobacteria.

14 November 2016 in AIDS Research and Therapy
Verified
Journal Article
Open access
PDF file
JMJared O. Mecha
Jared O. Mecha
EKElizabeth N. Kubo
Elizabeth N. Kubo
LNLucy W. Nganga
Lucy W. Nganga
PMPeter N. Muiruri
Peter N. Muiruri
LNLilian N. Njagi
Lilian N. Njagi
ZNZipporah W. Ngumi
Zipporah W. Ngumi
The success of antiretroviral therapy in resource-scarce settings is an illustration that complex healthcare interventions can be successfully delivered even in fragile health systems. Documenting the success factors in the scale-up of HIV care and treatment in resource constrained settings will enable health systems to prepare for changing population health needs. This study describes changing demographic and clinical characteristics of adult pre-ART cohorts, and identifies predictors of pre-ART attrition at a large urban HIV clinic in Nairobi, Kenya. We conducted a retrospective cohort analysis of data on HIV infected adults (≥15 years) enrolling in pre-ART care between January 2004 and September 2015. Attrition (loss to program) was defined as those who died or were lost to follow-up (having no contact with the facility for at least 6 months). We used Kaplan-Meier survival analysis to determine time to event for the different modes of transition, and Cox proportional hazards models to determine predictors of pre-ART attrition. Over the 12 years of observation, there were increases in the proportions of young people (age 15 to 24 years); and patients presenting with early disease (by WHO clinical stage and higher median CD4 cell counts), p = 0.0001 for trend. Independent predictors of attrition included: aHR (95% CI): male gender 1.98 (1.69–2.33), p = 0.0001; age 20–24 years 1.80 (1.37–2.37), p = 0.0001), or 25–34 years 1.22 (1.01–1.47), p = 0.0364; marital status single 1.55 (1.29–1.86), p = 0.0001) or divorced 1.41(1.02–1.95), p = 0.0370; urban residency 1.83 (1.40–2.38), p = 0.0001; CD4 count of 0–100 cells/µl 1.63 (1.003–2.658), p = 0.0486 or CD4 count >500 cells/µl 2.14(1.46–3.14), p = 0.0001. In order to optimize the impact of HIV prevention, care and treatment in resource scarce settings, there is an urgent need to implement prevention and treatment interventions targeting young people and patients entering care with severe immunosuppression (CD4 cell counts <100 cells/µl). Additionally, care and treatment programmes should strengthen inter-facility referrals and linkages to improve care coordination and prevent leakages in the HIV care continuum.